Ingersoll Rand Inc. is a diversified industrial company that designs and manufactures mission-critical flow-creation equipment, including air compressors, vacuum and blower systems, power tools, and precision fluid-handling technologies. The business operates through two segments — Industrial Technologies and Services, and Precision and Science Technologies — and generates a meaningful share of revenue from higher-margin aftermarket parts and services tied to its large installed base. Headquartered in Davidson, North Carolina, the company was formerly known as Gardner Denver Holdings before adopting the Ingersoll Rand name in 2020.
IR shares trade around $75 after a sharp pullback from their February 2026 52-week high of roughly $101, a decline of about 26%. The stock's 52-week range spans from about $68 on the low end to just above $100 on the high end, placing the $110 target well above anything the shares have achieved. With a market capitalization near $30 billion and a trailing price-to-earnings (P/E) ratio in the low 30s, Ingersoll Rand continues to command a premium multiple relative to many industrial machinery peers.
The $110 target is notable because it sits just above the stock's all-time high zone near $101. It represents the next logical psychological milestone for a name that has already demonstrated it can trade near the century mark. It also aligns closely with the highest published analyst price targets on the stock — both Robert W. Baird and Citigroup have set objectives at $109 — giving the level a foothold in real Wall Street research rather than being an arbitrary number.
Several factors could support a sustained move toward $110. First, the company has a track record of exceeding consensus expectations; recent quarters have delivered earnings and revenue beats, with revenue growing at a high-single-digit percentage year over year. Second, Ingersoll Rand's aggressive bolt-on acquisition strategy has been a reliable engine of inorganic growth, with more than a dozen smaller deals completed in 2025 that broaden its product portfolio and aftermarket revenue base. Third, its high-margin Precision and Science Technologies segment, which serves life sciences and specialized industrial applications, offers a growth profile that supports the stock's premium valuation. Finally, share repurchases — the company has returned billions through buybacks — steadily reduce the share count and mechanically lift earnings per share (EPS) even if net income is flat.
The path to $110 is not without friction. Organic growth in certain core industrial and energy-related end markets has been uneven, and management has guided to only modest revenue growth for the current year. The company's net debt has risen following its acquisition push, pushing leverage above its stated target and potentially constraining future capital allocation. A trailing P/E in the low 30s leaves relatively little margin for error: if earnings estimates are revised downward or the multiple compresses toward the peer average, the stock could struggle to regain its former highs. Broader macro uncertainty — including tariff-related cost pressures and cyclical softness in industrial capital spending — remains a persistent risk to the outlook.
Wall Street's view on Ingersoll Rand is constructive but not uniformly bullish. The consensus rating hovers between "Moderate Buy" and "Hold," with an average 12-month price target in the mid-$90s — implying meaningful upside from current levels but still well below $110. The dispersion is wide: more cautious firms such as Morgan Stanley and Evercore carry targets in the low-to-mid $80s, while bullish houses including Robert W. Baird and Citigroup sit near $109. In other words, reaching $110 would require the stock to realize the most optimistic end of the analyst range, not the consensus.
From a technical analysis perspective, the $68 zone — the 52-week low — stands as the critical support level that has held on multiple tests. On the upside, the prior high near $101 is the most important resistance level and a supply area where sellers previously emerged. Any credible move toward $110 would likely unfold in stages: first a recovery toward the mid-$80s to low-$90s, where the 200-day moving average and several analyst targets cluster, then a retest of the $101 high, and only then an extension toward $110. The $100 mark also carries psychological weight as a round number investors tend to anchor on.
Traders monitoring names like Ingersoll Rand can supplement their own research with automated tools such as Tickeron's AI Daily Buy/Sell Signals. The product uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. These signals are designed to help traders discover new opportunities, keep track of existing positions, and identify shifting market trends more efficiently. Exploring these AI-generated signals may offer an additional layer of context for evaluating whether a price move is gaining or losing momentum.
Can Ingersoll Rand realistically reach $110? The evidence points to a qualified yes over a multi-year horizon, but not as an imminent event. The bullish case — consistent earnings beats, an active acquisition pipeline, a high-margin precision technology segment, and steady buybacks — provides a credible foundation for eventual new highs. The counterweights are equally real: a premium valuation, uneven organic growth, elevated leverage, and the fact that the consensus analyst target sits materially below $110. Investors should watch whether the stock can reclaim its $101 prior high, whether organic orders reaccelerate, and whether leverage trends back toward management's target. Those developments, rather than the headline price alone, will likely determine whether the $110 objective is achievable.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, IR has been closely correlated with JCI. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if IR jumps, then JCI could also see price increases.
| Ticker / NAME | Correlation To IR | 1D Price Change % |
|---|---|---|
| IR | 100% | -3.13% |
| IR (8 stocks) | 79% Closely correlated | +0.42% |
| Producer Manufacturing (347 stocks) | 20% Poorly correlated | +0.82% |